The U.S. Food and Drug Administration (FDA) on Thursday approved a new type of prescription pain medication for adults to treat moderate to severe acute pain. The drug, called Journavx (suzetrigine) ...

A new non-opioid pain medication has been released - and doctors say it is non-addictive. The new drug, branded "Journavx," is the first non-opioid pain pill, and it just got FDA approval. "It's not ...

Last week, the Food and Drug Administration approved Journavx, the first non-addictive opioid-like pain medication. Scientific discoveries at Yale were key to the development of the drug. Journavx, ...

For the last quarter century, one of the world’s most capable drug developers toiled to make a new, non-addictive kind of painkiller. The journey was fittingly excruciating. Pain, as Vertex ...

Federal officials approved a new non-opioid painkiller developed by a Boston pharmaceutical company on Thursday, calling it a “first-in-class” treatment that avoids the addictive risks of opioid-based ...

The U.S. Food and Drug Administration (FDA) created a major media stir last week when it announced the approval of suzetrigine (brand name Journavx), a unique new non-opioid, non-addictive drug for ...

The new method is designed to focus specifically on pain-related signals, without interfering with normal activity in other parts of the brain. A new preclinical study has identified a gene therapy ap ...

A new compound provides the pain-relieving properties of cannabis - without the mind-bending side effects. It may be an ...